- Prescription Drugs
- Over-the-Counter Drugs
Africa Pharmaceuticals Market size was valued at USD x billion in 2021 and is expected to reach USD x billion by 2028, at a CAGR of x% during the forecast period 2022 to 2028. In addition, expansion of businesses by the pharmaceutical companies, environmental conditions such as tropical climate in Africa may cause the infectious diseases such as TB, malaria, and AIDS, and economic growth are expected to propel the Africa pharmaceuticals market. However, high cost of pharmaceuticals for chronic diseases, and lack of awareness about the disease treatments in underdeveloped countries may hamper the growth of This market.
Africa Pharmaceuticals Market Dynamics
Increase in the prevalence of chronic diseases such as cancer, diabetes, cardiovascular diseases, rise in R&D activities for the innovation of newer drugs, and increase in healthcare expenditure are anticipated to fuel the Africa pharmaceuticals market over the forecast period.
Africa Pharmaceuticals Market
Africa Pharmaceuticals Market
Geographically, Africa pharmaceuticals market is segmented into North Africa, Central Africa, South Africa, and rest of Africa. North Africa pharmaceuticals market is growing at a significant rate owing to increase in the prevalence of malaria, leishmaniasis, rickettsioses, and leishmaniasis in Algeria, Egypt, Libya, and Tunisia. Central Africa pharmaceuticals market has a lucrative growth owing to rise in prevalence of malaria, cholera, and tuberculosis due to tropical climate, rise in incidence of AIDS especially in women, and rapid urbanization are boost the market. Southern Africa pharmaceuticals market has a significant share attributed to awareness about diseases treatment majorly in South Africa, rise in R&D for the innovation of newer drugs, and expansion of business by market players in the region.
Latin America
Europe
Asia Pacific
Middle East
North America
Africa Pharmaceuticals Market Segmentation
product type
formulation
- Solid
- Liquid
- Semi-Solid
therapeutic area
- Infectious Diseases
- Cardiovascular Diseases
- Diabetes and Metabolic Disorders
- Neurological Diseases
- Cancer
- Autoimmune Disorders
- Others
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
Frequently Asked Questions
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
Key Features of the Report
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
- Executive Summary
- Africa Pharmaceuticals Market Introduction
- Africa Pharmaceuticals Market – Taxonomy
- Africa Pharmaceuticals Market –Definitions
- Product Type
- Formulation
- Therapeutic area
- Distribution Channel
- Africa Pharmaceuticals Market Dynamics
- Drivers
- Restraints
- Opportunities/Unmet Needs of the Market
- Trends
- Africa Pharmaceuticals Market Dynamic Factors - Impact Analysis
- Africa Pharmaceuticals Market – Competition Landscape
- Epidemiology
- Africa Pharmaceuticals Market Analysis,2013 - 2017 and Forecast, 2018 – 2024
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%)
- Market OpportunityAnalysis
- Africa Pharmaceuticals Market, By Product Type, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Prescription Drugs
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Over-the-Counter Drugs
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Prescription Drugs
- Africa Pharmaceuticals Market Forecast, By Formulation,2013 - 2017 and Forecast, 2017 – 2024
- Solid
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Liquid
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Semi-Solid
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Solid
- Africa Pharmaceuticals Market Forecast, By Therapeutic Area, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Infectious Diseases
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Cardiovascular Diseases
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Diabetes and Metabolic Disorders
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Neurological Diseases
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Cancer
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Autoimmune Disorders
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Others
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Infectious Diseases
- Africa Pharmaceuticals Market Forecast, By Distribution Channel, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Hospital Pharmacies
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Retail Pharmacies
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Hospital Pharmacies
- Africa Pharmaceuticals Market Forecast, By Region, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- North Africa
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Central Africa
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Southern Africa
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Rest of Africa
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Africa Pharmaceuticals Market - Opportunity Analysis Index, By Product Type, By Formulation, By Therapeutic Area, By Distribution Channel, and Region, 2018 – 2024
- North Africa
- North Africa Pharmaceuticals MarketAnalysis,2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Product Type Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Prescription Drugs
- Over-the-Counter Drugs
- Formulation Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Solid
- Liquid
- Semi-Solid
- Therapeutic Area Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Infectious Diseases
- Cardiovascular Diseases
- Diabetes and Metabolic Disorders
- Neurological Diseases
- Cancer
- Autoimmune Disorders
- Others
- Distribution Channel Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Hospital Pharmacies
- Retail Pharmacies
- North Africa Pharmaceuticals Market - Opportunity Analysis Index, By Product Type, By Formulation, By Therapeutic Area, By Distribution Channel, and Region, 2018 – 2024
- North Africa Pharmaceuticals Market Dynamics – Trends
- Product Type Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Central Africa Pharmaceuticals Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Product Type Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Prescription Drugs
- Over-the-Counter Drugs
- Formulation Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Solid
- Liquid
- Semi-Solid
- Therapeutic Area Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Infectious Diseases
- Cardiovascular Diseases
- Diabetes and Metabolic Disorders
- Neurological Diseases
- Cancer
- Autoimmune Disorders
- Others
- Distribution Channel Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Hospital Pharmacies
- Retail Pharmacies
- Central Africa Pharmaceuticals Market - Opportunity Analysis Index, By Product Type, By Formulation, By Therapeutic Area, By Distribution Channel, and Region, 2018 – 2024
- Central Africa Pharmaceuticals Market Dynamics – Trends
- Product Type Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Southern Africa Pharmaceuticals Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Product Type Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Prescription Drugs
- Over-the-Counter Drugs
- Formulation Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Solid
- Liquid
- Semi-Solid
- Therapeutic Area Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Infectious Diseases
- Cardiovascular Diseases
- Diabetes and Metabolic Disorders
- Neurological Diseases
- Cancer
- Autoimmune Disorders
- Others
- Distribution Channel Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Hospital Pharmacies
- Retail Pharmacies
- Southern Africa Pharmaceuticals Market - Opportunity Analysis Index, By Product Type, By Formulation, By Therapeutic Area, By Distribution Channel, and Region, 2018 – 2024
- Southern Africa Pharmaceuticals Market Dynamics – Trends
- Product Type Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Rest of Africa Pharmaceuticals Market Analysis, 2012 - 2012 - 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Product Type Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Prescription Drugs
- Over-the-Counter Drugs
- Formulation Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Solid
- Liquid
- Semi-Solid
- Therapeutic Area Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Infectious Diseases
- Cardiovascular Diseases
- Diabetes and Metabolic Disorders
- Neurological Diseases
- Cancer
- Autoimmune Disorders
- Others
- Distribution Channel Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Hospital Pharmacies
- Retail Pharmacies
- Rest of Africa Pharmaceuticals Market - Opportunity Analysis Index, By Product Type, By Formulation, By Therapeutic Area, By Distribution Channel, and Region, 2018 – 2024
- Rest of Africa Pharmaceuticals Market Dynamics – Trends
- Product Type Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Competition Landscape
- Strategic Dashboard of Top Market Players
- Company Profiles (Introduction, Financial Analysis, Drug Class& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
- GlaxoSmithKline Plc. (UK)
- Pfizer Inc. (U.S.)
- Novartis AG (Switzerland)
- Sanofi S.A. (France)
- AstraZeneca plc (UK)
- Cipla Ltd. (India)
- Bayer AG (Germany)
- Resmed Pharmaceuticals Cc(South Africa)
- Aspen Holdings (South Africa)
- Litha Healthcare Group (Pty) Ltd (South Africa)
- Research Methodology
Key Assumptions and Acronyms
- GlaxoSmithKline Plc. (UK)
- Pfizer Inc. (U.S.)
- Novartis AG (Switzerland)
- Sanofi S.A. (France)
- AstraZeneca plc (UK)
- Cipla Ltd. (India)
- Bayer AG (Germany)
- Resmed Pharmaceuticals Cc (South Africa)
- Aspen Holdings (South Africa)
- Litha Healthcare Group (Pty) Ltd (South Africa)